Efficacy outcomes and characteristics of patients with multiple myeloma (mm) who achieved sustained minimal residual disease negativity after treatment with ciltacabtagene autoleucel (cilta-cel) in CARTITUDE-1 Meeting Abstract
| Authors: | Munshi, N.; Pavia, B.; Martin, T.; Usmani, S.; Lin, Y.; Schecter, J.; Jackson, C.; Madduri, D.; Zudaire, E.; Yeh, T. M.; Bartlett, J. B.; Pacaud, L.; Akram, M.; Geng, D.; Jagannath, S.; Cohen, A.; San-Miguel, J. |
| Abstract Title: | Efficacy outcomes and characteristics of patients with multiple myeloma (mm) who achieved sustained minimal residual disease negativity after treatment with ciltacabtagene autoleucel (cilta-cel) in CARTITUDE-1 |
| Meeting Title: | 11th Annual Meeting of the Society of Hematologic Oncology (SOHO 2023): Progress in Personalized Therapy |
| Keywords: | multiple myeloma; disease; mm; minimal residual; car-t cell therapy; cilta-cel |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 23 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Sep 6-9 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-09-01 |
| Start Page: | S487 |
| End Page: | S488 |
| Language: | English |
| ACCESSION: | WOS:001062479600564 |
| PROVIDER: | wos |
| DOI: | 10.1016/S2152-2650(23)01431-3 |
| Notes: | Meeting Abstract: MM-304 -- Source: Wos |
